rxstat › Shortages › Captopril
Captopril shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Captopril is in a widespread shortage in Canada. 6 of 9 reported products are affected. Manufacturers have not committed to a recovery date.
In shortage since
Sep 24, 2024
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTEVA-CAPTOPRIL
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 01942964 · since Apr 8, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageTEVA-CAPTOPRIL
25MG · TABLET · TEVA CANADA LIMITED
DIN 01942972 · since Apr 8, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageTEVA-CAPTOPRIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 01942999 · since Apr 8, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-CAPTO TAB 50MG
50MG · TABLET · APOTEX INC
DIN 00893617 · since Sep 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortageTEVA-CAPTOPRIL
50MG · TABLET · TEVA CANADA LIMITED
DIN 01942980 · since Jul 2, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-CAPTO TAB 25MG
25MG · TABLET · APOTEX INC
DIN 00893609 · since Sep 24, 2024, no end estimate · Disruption of the manufacture of the drug.
AnticipatedAPO-CAPTO TAB 12.5MG
12.5MG · TABLET · APOTEX INC
DIN 00893595 · Disruption of the manufacture of the drug.
AnticipatedAPO-CAPTO TAB 100MG
100MG · TABLET · APOTEX INC
DIN 00893625 · Disruption of the manufacture of the drug.
DiscontinuedTEVA-CAPTOPRIL
25MG · TABLET · TEVA CANADA LIMITED
DIN 01942972
ResolvedTEVA-CAPTOPRIL
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 01942964 · ended Aug 8, 2022 · Disruption of the manufacture of the drug.
ResolvedTEVA-CAPTOPRIL
50MG · TABLET · TEVA CANADA LIMITED
DIN 01942980 · ended Jul 15, 2021 · Disruption of the manufacture of the drug.
ResolvedTEVA-CAPTOPRIL
50MG · TABLET · TEVA CANADA LIMITED
DIN 01942980 · ended May 5, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
Captopril is currently affected by 6 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Captopril is classified under “ACE INHIBITORS, PLAIN” (ATC C09AA).
Recent changes
Common questions
When will Captopril be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Captopril in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All ace inhibitors, plain shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.